-
Regulus Therapeutics (RGLS) Announces Strategic Update and Corporate Restructuring; to Pause Phase 1 MAD Study for RGLS4326
-
Regulus Announces Strategic Update and Corporate Restructuring
-
Regulus Reports Second Quarter 2017 Financial Results and Recent Events
-
Pre-Open Movers 05/05: (IMMU) (SNCR) (ZFGN) Higher; (APHB) (BCOV) (RGLS) Lower (more...)
-
After-Hours Stock Movers 05/04: (ZFGN) (OLED) (WING) Higher; (BCOV) (RGLS) (AMSC) Lower (more...)
-
Regulus Therapeutics (RGLS) Misses Q1 EPS by 3c, Announces Workforce Reduction; CEO to Resign
-
Regulus Reports First Quarter 2017 Financial Results and Corporate Restructuring